Pfizer’s former R&D chief Dolsten pulls out of Novo Nordisk board race
(Reuters) -Mikael Dolsten, Pfizer’s former research and development chief, has withdrawn his candidacy for Novo Nordisk’s board, citing personal reasons, the Danish drugmaker said on Thursday. Dolsten, who led Pfizer’s R&D operations until 2024, informed Novo that he would not seek election at Friday’s extraordinary general meeting. He has previously held senior R&D roles at …
Pfizer’s former R&D chief Dolsten pulls out of Novo Nordisk board race Read More »










